Melinta Therapeutics and Xediton Pharmaceuticals Announce Licensing Agreement to Commercialize Anti-Infective Products in Canada
Losec® MUPS 20mg Tablets – NOW AVAILABLE
Xediton Pharmaceuticals Inc would like to inform you of the introduction of PrLOSEC® (Omeprazole Magnesium) Tablets, Capsules, on June 20th, 2021
Please note that the Losec® MUPS 20mg tablets have replaced the previous version of the 20mg tablets that were available as blisters of 2×15, 10×10, and bottles of 100 tables. DIN 02190915 as of June 2021
The MUPS tablet format is very similar to the current Tablet format when compared across Therapeutic classification, Actions and Clinical Pharmacology, Indications, Contraindications, Warnings, Precautions, Drug Interactions, Adverse Reactions, Dosage and Administration, Composition, Stability and Storing, Dosage Forms, Absorption and Distribution, Metabolism and Excretion, Pharmacodynamics (Human Pharmacology), Pharmacokinetics, Toxicology.
The rest of the world has substituted the Tablets format with the MUPS tablet format. Canada is one of the few countries that have not switched to the MUPS tablet yet.
There are currently two formulations of Brand Name Losec® available to patients
| DIN Number | UPC Code | Item Code | Product Name | Generic Name | Strength/ Description |
| 00846503 | 4260095684547 | 436029 | Losec, 20mg Capsules | Omeprazole | 20mg Caps, 30s |
| 02242462 | 4260095684257 | 842030 | Losec, 20mg MUPS Tablets | Omeprazole
| 20mg Tab, 50s |